29 November 2023
29 November 2023 Cordiant Digital Infrastructure Limited Interim report for the six months ended 30 September 2023 Solid performance, reflecting strength of underlying portfolio Cordiant…
29 November 2023 Half Year Results 2023/24 Susan Davy, Group Chief Executive, commented: Pennon has continued to make progress in the last six months…
28 November 2023
Results for the year to 30 September 2023 Over the year to 30 September 2023, the Company’s net asset value per share (NAV) total…
28 November 2023 Troy Income & Growth Trust plc Combination with STS Global Income & Growth Trust plc Introduction Further to the Company’s announcement on 2…
Resilient sales performance Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and…
27 November 2023
27 November 2023 Concurrent Technologies Plc (the ‘Company’) Trading Update Concurrent Technologies Plc (AIM: CNC), a world-leading specialist in the design and manufacture of…
GSK announces positive results from DREAMM-7 head-to-head phase III trial for Blenrep in relapsed/refractory multiple myeloma · Blenrep (belantamab mafodotin) plus BorDex showed statistically significant progression-free survival (PFS)…
M. P. EVANS GROUP PLC (“THE GROUP”) COMPLETION OF NEW LAND ACQUISITION M.P. Evans Group PLC, a producer of sustainable Indonesian palm oil, is pleased…